SARS-COV-2 Rapid Antigen Test in Comparison with RT-PCR for Laboratory Diagnosis of COVID-19 in a Southwest State of Nigeria ()
Affiliation(s)
1Department of Epidemiology and Medical Statistics, University of Ibadan, Ibadan, Nigeria.
2Ondo State Ministry of Health, Akure, Nigeria.
3Nigeria Field Epidemiology and Laboratory Training Programme, Abuja, Nigeria.
4Ondo State Primary Health Care Development Agency, Akure, Nigeria.
5Medical Laboratory Science Council of Nigeria, Abuja, Nigeria.
6Department of Community Medicine, University of Medical Sciences, Ondo, Nigeria.
ABSTRACT
Objectives: Rapid and accurate identification of persons infected with SARS-CoV-2 which causes COVID-19 is key to managing the pandemic. The urgent need to scale up access to COVID-19 testing in Nigeria has led to the government’s introduction of the use of COVID-19 Ag rapid diagnostic test (RDT) across various settings in the country. However, field performance evaluation of the rapid SARS-CoV-2 antigen detection test is required to be conducted periodically and compared with the gold standard real-time reverse transcription-polymerase chain reaction (RT-PCR) test for diagnosis of COVID-19 cases. Design: A prospective COVID-19 screening and un-blinded verification of the performance of the STANDARD Q COVID-19 Ag test kit. Setting: The rapid SARS-CoV-2 antigen detection test, StandardTM Q COVID-19 Ag kit was compared with the RT-PCR test for detection of SARS-CoV-2 in nasopharyngeal samples for COVID-19 screening from persons and personnel attending a national youth camp orientation exercise during the second wave of the COVID-19 outbreak (January to March 2021) in Ondo state, southwest Nigeria. Participants: Three hundred fifty-one persons and personnel were screened for COVID-19 infection. Results: Of 351 respondents screened, 68 (19.4%) were positive, and 264 (75.2%) were negative for both COVID-19 Ag RDT and RT-PCR assay. The rapid SARS-CoV-2 antigen detection test’s sensitivity and specificity were 78.16% (95% CI = 68.02% - 86.31%) and 100.0% (95% CI = 98.61% - 100.0%), respectively and the diagnostic accuracy was 94.59% (95% CI: 92 - 97). Respondents that were symptomatic had a higher test sensitivity of 78.6% (49.2 - 95.3) compared to those without symptoms 78.1% (66.9 - 86.9) (p < 0.05). Conclusions: Our study shows evidence that StandardTM Q COVID-19 Ag kit can be an appropriate rapid antigen test that could be used to screen for positive COVID-19 tests to guide decision-making for clinical management of persons infected with COVID-19, especially for closed settings and other clinical care settings.
Share and Cite:
Isere, E. , Oluwole, M. , Adejugbagbe, M. , Omoju, T. , Oni, O. , Ajayi, I. , Omorogbe, N. , Fagbemi, T. and Fagbemi, S. (2022) SARS-COV-2 Rapid Antigen Test in Comparison with RT-PCR for Laboratory Diagnosis of COVID-19 in a Southwest State of Nigeria.
Open Journal of Epidemiology,
12, 387-400. doi:
10.4236/ojepi.2022.124032.
Cited by
No relevant information.